- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate cancer vaccines in clinical trials
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 11, Issue 7, Pages 857-868
Publisher
Informa UK Limited
Online
2012-08-22
DOI
10.1586/erv.12.54
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The evolution of antiandrogens: MDV3100 comes of age
- (2012) Lucy Dumas et al. Expert Review of Anticancer Therapy
- Under-Representation of Older Adults in Cancer Registration Trials: Known Problem, Little Progress
- (2012) Kevin S. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer
- (2012) M. L. Huber et al. JNCI-Journal of the National Cancer Institute
- Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
- (2012) Ravi A Madan et al. LANCET ONCOLOGY
- Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial
- (2011) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN
- (2011) S. M. Geary et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
- (2011) T. M. Beer et al. CLINICAL CANCER RESEARCH
- Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies
- (2011) L. Apetoh et al. CURRENT MOLECULAR MEDICINE
- DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen
- (2011) Gisella E. Vittes et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Therapeutic vaccination for cancer immunotherapy: Antigen selection and clinical responses
- (2011) Astrid Geldmacher et al. Human vaccines & immunotherapeutics
- Co-delivery of PSA and PSMA DNA vaccines with electroporation induces potent immune responses
- (2011) Bernadette Ferraro et al. Human vaccines & immunotherapeutics
- Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination
- (2011) Junji Kawada et al. INTERNATIONAL JOURNAL OF CANCER
- A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors
- (2011) Jeffrey S. Weber et al. JOURNAL OF IMMUNOTHERAPY
- Concerns About Provenge Simmer as CMS Ponders Coverage
- (2011) M. Goozner JNCI-Journal of the National Cancer Institute
- A methodological framework to enhance the clinical success of cancer immunotherapy
- (2011) Axel Hoos et al. NATURE BIOTECHNOLOGY
- Listening to Provenge — What a Costly Cancer Treatment Says about Future Medicare Policy
- (2011) James D. Chambers et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T: Prototype for Development of Anti-tumor Vaccines
- (2011) Estrella Carballido et al. Current Oncology Reports
- Assessing oncologic benefit in clinical trials of immunotherapy agents
- (2010) R. K. Hales et al. ANNALS OF ONCOLOGY
- A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer
- (2010) Masanori Noguchi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Anti-tumor immune response induced by dendritic cells transduced with truncated PSMA IRES 4-1BBL recombinant adenoviruses
- (2010) Kuang Youlin et al. CANCER LETTERS
- Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy
- (2010) W. D. Stein et al. CLINICAL CANCER RESEARCH
- HER-2/neu as a target for cancer vaccines
- (2010) Constantin N Baxevanis et al. Immunotherapy
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical Evaluation of a Recombinant Anti-Prostate Specific Membrane Antigen Single-Chain Immunotoxin Against Prostate Cancer
- (2010) Philipp Wolf et al. JOURNAL OF IMMUNOTHERAPY
- DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer
- (2010) Jordan T. Becker et al. JOURNAL OF IMMUNOTHERAPY
- Sipuleucel-T
- (2010) Celestia S. Higano et al. NATURE REVIEWS DRUG DISCOVERY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression
- (2010) R. A. Madan et al. ONCOLOGIST
- A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer
- (2010) Masanori Noguchi et al. PROSTATE
- Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression
- (2010) Magdalena Krupa et al. VACCINE
- Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
- (2009) James L. Gulley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
- (2009) Hirotsugu Uemura et al. CANCER SCIENCE
- Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
- (2009) D. M. Lubaroff et al. CLINICAL CANCER RESEARCH
- NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells
- (2009) S. Gnjatic et al. CLINICAL CANCER RESEARCH
- Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen
- (2009) U. Elsasser-Beile et al. CURRENT DRUG TARGETS
- Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer
- (2009) Ravi A Madan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer
- (2009) Gerhardt Attard et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer
- (2009) Douglas G. McNeel et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
- (2008) Celestia S. Higano et al. CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now